26 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
22 Feb 24
Maravai Lifesciences Reports Fourth Quarter and Full Year 2023 Financial Results
4:08pm
Commercial Officer, recognized on the Healthcare Technology Report’s list of Top 25 Women Leaders in Biotechnology of 2023.
"We closed out a challenging 2023
424B4
9syhxdn 429l8xwnr
13 Sep 21
Prospectus supplement with pricing info
4:16pm
DRS
rql zczja
26 Aug 21
Draft registration statement
12:00am
DEF 14A
pfplw3e
19 Apr 21
Definitive proxy
4:46pm
PRE 14A
7jpwex682ey 3btwghzi
9 Apr 21
Preliminary proxy
4:16pm
424B4
1a6 czi01msiqxcfc9ib
9 Apr 21
Prospectus supplement with pricing info
4:02pm
CORRESP
t2h 8igioc3o6
5 Apr 21
Correspondence with SEC
12:00am
DRS
imn fj55xdwz5
25 Mar 21
Draft registration statement
12:00am
10-K
78d9i2q3bb1t9xi5y5y0
22 Mar 21
Annual report
4:22pm
8-K
EX-1.1
env2af2s7 b4j
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
424B4
8d2i h1d17
23 Nov 20
Prospectus supplement with pricing info
4:36pm